The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Differential Cerebral Metabolic Changes With Paroxetine Treatment of Obsessive-Compulsive Disorder vs Major Depression
Abstract
BACKGROUND: Serotonin reuptake inhibitors (SRIs) effectively treat both major depressive disorder (MDD) and obsessive-compulsive disorder (OCD). We compared and contrasted the functional neuroanatomical effects of SRIs in OCD and MDD as these 2 disorders occurred separately and concurrently by measuring pretreatment to posttreatment cerebral glucose metabolic changes in OCD vs MDD vs concurrent OCD + MDD. METHODS: We obtained [(18)F]fluorodeoxyglucose positron emission tomography (PET) brain scans on 25 subjects with OCD, 25 with MDD, and 16 with concurrent OCD + MDD before and after 8 to 12 weeks of treatment with paroxetine hydrochloride. Controls (n = 16) were scanned 10 to 12 weeks apart without treatment. Treatment response was defined as a more than 25% decline in OCD symptom severity, a more than 50% decline in MDD severity, and "much improved" clinical global impression. RESULTS: Although all patient groups received the same paroxetine dose for the same duration, regional metabolic changes differed significantly among diagnostic groups. Subjects with OCD alone showed significant metabolic decreases in the right caudate nucleus, right ventrolateral prefrontal cortex (VLPFC), bilateral orbitofrontal cortex, and thalamus that were not seen in any other group. Both the MDD and concurrent OCD + MDD groups showed metabolic decreases in the left VLPFC and increases in the right striatum. Treatment response was associated with a decrease in striatal metabolism in nondepressed OCD patients but with an increase in striatal activity in patients with OCD + MDD. CONCLUSIONS: Brain metabolic responses to SRIs are both disorder-specific and response-specific. They vary according to the underlying pathophysiology of the patient and the degree of symptomatic improvement.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Yale-Brown Obsessive Compulsive Scale: I. Development, Use, and Reliability
Goodman, W. K. (1989) · Archives of General Psychiatry · doi:10.1001/archpsyc.1989.01810110048007 · Cited by 7,712
The Global Assessment Scale: A Procedure for Measuring Overall Severity of Psychiatric Disturbance
Endicott, J. (1976) · Archives of General Psychiatry · doi:10.1001/archpsyc.1976.01770060086012 · Cited by 4,982
Mayberg, H. S., Liotti, M., Brannan, S. K., McGinnis, S., Mahurin, R. K., Jerabek, P. A., Silva, J. A., Tekell, J. L., Martin, C. C., Lancaster, J. L., et al. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.5.675 · Cited by 2,416
Limbic-cortical dysregulation: a proposed model of depression
(1997) · The Journal of Neuropsychiatry and Clinical Neurosciences · doi:10.1176/jnp.9.3.471 · Cited by 1,585
Baxter, L. R. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820090009002 · Cited by 1,293
Self-citationNeuroanatomical correlates of externally and internally generated human emotion
(1997) · American Journal of Psychiatry · doi:10.1176/ajp.154.7.918 · Cited by 711
Cerebral glucose metabolic rates in nondepressed patients with obsessive-compulsive disorder
(1988) · American Journal of Psychiatry · doi:10.1176/ajp.145.12.1560 · Cited by 541
Self-citationSaxena, S. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00082-2 · Cited by 379
Self-citationFrontal and parietal metabolic disturbances in unipolar depression
Biver, F., Goldman, S., Delvenne, V., Luxen, A., De Maertelaer, V., Hubain, P., Mendlewicz, J., & Lotstra, F. (1994) · Biological Psychiatry · doi:10.1016/0006-3223(94)91213-0 · Cited by 313
Dorsolateral prefrontal cortex dysfunction in the major psychoses; symptom or disease specificity?
Dolan, R. J., Bench, C. J., Liddle, P. F., Friston, K. J., Frith, C. D., Grasby, P. M., & Frackowiak, R. S. (1993) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.56.12.1290 · Cited by 261
Cited by
Imaging dopamine's role in drug abuse and addiction
Volkow, N. D., Fowler, J. S., Wang, G. J., Baler, R., & Telang, F. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.05.022 · Cited by 988
Mataix-Cols, D., Wooderson, S., Lawrence, N., Brammer, M. J., Speckens, A., & Phillips, M. L. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.6.564 · Cited by 929
The role of the hippocampus in the pathophysiology of major depression
Campbell, S., & MacQueen, G. (2004) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0441 · Cited by 880
Subtype-Specific Alterations of γ-Aminobutyric Acid and Glutamatein Patients With Major Depression
Sanacora, G., Gueorguieva, R., Epperson, C. N., Wu, Y.-T., Appel, M., Rothman, D. L., Krystal, J. H., & Mason, G. F. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.7.705 · Cited by 796
Obsessive-compulsive disorder: An integrative genetic and neurobiological perspective
Pauls, D. L., Abramovitch, A., Rauch, S. L., & Geller, D. A. (2014) · Nature Reviews Neuroscience · doi:10.1038/nrn3746 · Cited by 793
Cognitive therapy versus medication for depression: treatment outcomes and neural mechanisms
DeRubeis, R. J., Siegle, G. J., & Hollon, S. D. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2345 · Cited by 690
Drevets, W. (2002) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(02)00102-5 · Cited by 581
Smolka, M. N., Schumann, G., Wrase, J., Grüsser, S. M., Flor, H., Mann, K., Braus, D. F., Goldman, D., Büchel, C., & Heinz, A. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.1792-04.2005 · Cited by 416
Error-related hyperactivity of the anterior cingulate cortex in obsessive-compulsive disorder
Fitzgerald, K. D., Welsh, R. C., Gehring, W. J., Abelson, J. L., Himle, J. A., Liberzon, I., & Taylor, S. F. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.10.038 · Cited by 378
Brain default-mode network dysfunction in addiction
Zhang, R., & Volkow, N. D. (2019) · NeuroImage · doi:10.1016/j.neuroimage.2019.06.036 · Cited by 363
Cerebral glucose metabolism in obsessive-compulsive hoarding
Saxena, S., Brody, A. L., Maidment, K. M., Smith, E. C., Zohrabi, N., Katz, E., Baker, S. K., & Baxter, L. R. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.6.1038 · Cited by 343
Self-citationPathophysiology of obsessive–compulsive disorder
Aouizerate, B., Guehl, D., Cuny, E., Rougier, A., Bioulac, B., Tignol, J., & Burbaud, P. (2004) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2004.02.004 · Cited by 341
Mantovani, A., Lisanby, S. H., Pieraccini, F., Ulivelli, M., Castrogiovanni, P., & Rossi, S. (2005) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145705005729 · Cited by 334
Konarski, J. Z., McIntyre, R. S., Kennedy, S. H., Rafi‐Tari, S., Soczynska, J. K., & Ketter, T. A. (2008) · Bipolar Disorders · doi:10.1111/j.1399-5618.2008.00435.x · Cited by 299
Price, R. B., Shungu, D. C., Mao, X., Nestadt, P., Kelly, C., Collins, K. A., Murrough, J. W., Charney, D. S., & Mathew, S. J. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.10.025 · Cited by 270
Anticevic, A., Hu, S., Zhang, S., Savic, A., Billingslea, E., Wasylink, S., Repovs, G., Cole, M. W., Bednarski, S., Krystal, J. H., et al. (2014) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.10.021 · Cited by 268
Widespread structural brain changes in OCD: a systematic review of voxel-based morphometry studies
Piras, F., Piras, F., Chiapponi, C., Girardi, P., Caltagirone, C., & Spalletta, G. (2015) · Cortex · doi:10.1016/j.cortex.2013.01.016 · Cited by 214
Pharmacotherapy of Obsessive-compulsive Disorder and Obsessive-Compulsive Spectrum Disorders
Denys, D. (2006) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2006.02.013 · Cited by 213
Saxena, S., Brody, A. L., Ho, M. L., Zohrabi, N., Maidment, K. M., & Baxter, L. R. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.3.522 · Cited by 210
Self-citationRoth, R. M., Saykin, A. J., Flashman, L. A., Pixley, H. S., West, J. D., & Mamourian, A. C. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.12.007 · Cited by 181
Shin, D.-J., Jung, W. H., He, Y., Wang, J., Shim, G., Byun, M. S., Jang, J. H., Kim, S. N., Lee, T. Y., Park, H. Y., et al. (2014) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.09.002 · Cited by 162
(2006) · PubMed · Cited by 159
Adams, K. H., Hansen, E. S., Pinborg, L. H., Hasselbalch, S. G., Svarer, C., Holm, S., Bolwig, T. G., & Knudsen, G. M. (2005) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145705005055 · Cited by 147
“…activity in the caudate nuclei, both in response to treatment with SSRI and behavioural therapy (Baxter et al., 1992 ; Hansen et al., 2002 ; Saxena et al., 1999, 2002 ; Schwartz et al., 1996), and also an increased cerebral blood flow was found in the caudate nucleus in symptom provocation…”
BackgroundSzeszko, P. R., MacMillan, S., McMeniman, M., Lorch, E., Madden, R., Ivey, J., Banerjee, S. P., Moore, G. J., & Rosenberg, D. R. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300399 · Cited by 141
“The potential inhibitory effects of the SRIs may depend on the underlying pathophysiology of the disorder (Saxena et al, 2002) however, and thus, our findings may not be generalizable to other clinical populations.”
ResultNabeyama, M., Nakagawa, A., Yoshiura, T., Nakao, T., Nakatani, E., Togao, O., Yoshizato, C., Yoshioka, K., Tomita, M., & Kanba, S. (2008) · Psychiatry Research: Neuroimaging · doi:10.1016/j.pscychresns.2007.11.001 · Cited by 137
Hoexter, M. Q., de Souza Duran, F. L., D'Alcante, C. C., Dougherty, D. D., Shavitt, R. G., Lopes, A. C., Diniz, J. B., Deckersbach, T., Batistuzzo, M. C., Bressan, R. A., et al. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2011.250 · Cited by 123
Zobel, A., Joe, A., Freymann, N., Clusmann, H., Schramm, J., Reinhardt, M., Biersack, H.-J., Maier, W., & Broich, K. (2005) · Psychiatry Research: Neuroimaging · doi:10.1016/j.pscychresns.2005.02.010 · Cited by 117
Le Jeune, F., Vérin, M., N'Diaye, K., Drapier, D., Leray, E., Du Montcel, S. T., Baup, N., Pelissolo, A., Polosan, M., Mallet, L., et al. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.06.033 · Cited by 116
Zhou, D.-D., Wang, W., Wang, G.-M., Li, D.-Q., & Kuang, L. (2017) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.03.033 · Cited by 106
Mantovani, A., Rossi, S., Bassi, B. D., Simpson, H. B., Fallon, B. A., & Lisanby, S. H. (2013) · Psychiatry Research · doi:10.1016/j.psychres.2013.08.054 · Cited by 98
Vouimba, R.-M., Muñoz, C., & Diamond, D. M. (2006) · Stress · doi:10.1080/10253890600610973 · Cited by 96
Wood, J., & Ahmari, S. E. (2015) · Frontiers in Systems Neuroscience · doi:10.3389/fnsys.2015.00171 · Cited by 85
“…of this idea, selective serotonin reuptake inhibitors, which are first-line treatments for OCD, decrease OFC metabolic activity; activity in both lateral and mOFC is more strongly reduced in treatment responsive patients than non-responsive patients (Swedo et al., 1992; Saxena et al., 1999, 2002).”
BackgroundROH, K. S., SHIN, M. S., KIM, M., HA, T., SHIN, Y., LEE, K. J., & KWON, J. S. (2005) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.2005.01411.x · Cited by 86
Kim, C.-H., Koo, M.-S., Cheon, K.-A., Ryu, Y.-H., Lee, J.-D., & Lee, H.-S. (2003) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-003-1245-7 · Cited by 82
Inhibition of thoughts and actions in obsessive-compulsive disorder: extending the endophenotype?
Morein-Zamir, S., Fineberg, N. A., Robbins, T. W., & Sahakian, B. J. (2010) · Psychological Medicine · doi:10.1017/s003329170999033x · Cited by 78
Morgiève, M., N'Diaye, K., Haynes, W. I. A., Granger, B., Clair, A.-H., Pelissolo, A., & Mallet, L. (2014) · Psychological Medicine · doi:10.1017/s0033291713002237 · Cited by 74
Lázaro, L., Caldú, X., Junqué, C., Bargalló, N., Andrés, S., Morer, A., & Castro-Fornieles, J. (2008) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2007.12.007 · Cited by 74
Suetens, K., Nuttin, B., Gabriëls, L., & Van Laere, K. (2014) · Journal of Nuclear Medicine · doi:10.2967/jnumed.113.126409 · Cited by 64
Zuo, C., Ma, Y., Sun, B., Peng, S., Zhang, H., Eidelberg, D., & Guan, Y. (2013) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2013.23 · Cited by 56
Baseline Brain Metabolism in Resistant Depression and Response to Transcranial Magnetic Stimulation
Martinot, M.-L. P., Martinot, J.-L., Ringuenet, D., Galinowski, A., Gallarda, T., Bellivier, F., Lefaucheur, J.-P., Lemaitre, H., & Artiges, E. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.161 · Cited by 55
Assessing the validity of current mouse genetic models of obsessive-compulsive disorder
Wang, L., Simpson, H. B., & Dulawa, S. C. (2009) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e32832a80ad · Cited by 50
Anxiety Disorders and Depression Comorbidity
Huppert, J. D. (2008) · Oxford Handbooks Online · doi:10.1093/oxfordhb/9780195307030.013.0044 · Cited by 37
Han, J. Y., Kang, D.-H., Gu, B.-M., Jung, W. H., Choi, J.-S., Choi, C.-H., Jang, J. H., & Kwon, J. S. (2011) · Journal of Korean Medical Science · doi:10.3346/jkms.2011.26.5.665 · Cited by 32
P300 in obsessive–compulsive disorder: Source localization and the effects of treatment
Andreou, C., Leicht, G., Popescu, V., Pogarell, O., Mavrogiorgou, P., Rujescu, D., Giegling, I., Zaudig, M., Juckel, G., Hegerl, U., et al. (2013) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2013.09.003 · Cited by 29
Neuroimaging and Neuropathological Studies of Mood Disorders
Drevets, W. C., & Price, J. L. (2005) · Biology of Depression · doi:10.1002/9783527619672.ch17 · Cited by 26
The orbitofrontal cortex and anxiety disorders
Milad, M. R., & Rauch, S. L. (2006) · The Orbitofrontal Cortex · doi:10.1093/acprof:oso/9780198565741.003.0020 · Cited by 11
Metadata
- Authors
- Saxena, S., Brody, A. L., Ho, M. L., Alborzian, S., Maidment, K. M., Zohrabi, N., Ho, M. K., Huang, S.-C., Wu, H.-M., & Baxter, L. R.
- Venue
- Archives of General Psychiatry
- Publisher
- American Medical Association (AMA)
- Published
- 2002-03-01
- Volume
- 59
- Issue
- 3
- Pages
- 250
- ISSN
- 0003-990X (ISSN-L)
- OpenAlex
- W2137286718
- Cited by
- 201
- References
- 11
- FWCI
- 21.77
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.